This study tests if SHPL-49 injections are safe and effective for people with acute ischemic stroke. This is a stroke caused by blocked blood flow in the brain. SHPL-49 is given through an IV, which is a tube that delivers medicine directly into the bloodstream, for 7 days. The study is a Phase II trial, meaning it's in the second stage of testing to see if the treatment works and is safe. It is also double-blind, so neither the patients nor the researchers know who is getting the real treatment or a placebo (a fake treatment). The study involves 270 people, divided into three groups to receive different doses or a placebo.
- Participants will visit the clinic for 7 days straight and will receive 14 doses in total.
- People aged 18-80 with certain medical conditions may join.
- Talk to your doctor about any risks or benefits before joining.
How understandable was the trial content above?
Hard to understand
Easy to understand